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Background: Adenosine triphosphate (ATP) is used as an intracellular energy source by all living organisms. It plays
a central role in the respiration and metabolism, and is the most important energy supplier in many enzymatic
reactions. Its critical role as the energy storage molecule makes it extremely valuable to all cells.
Results: We report here the detection of extracellular ATP in the cultures of a variety of bacterial species. The levels
of the extracellular ATP in bacterial cultures peaked around the end of the log phase and decreased in the
stationary phase of growth. Extracellular ATP levels were dependent on the cellular respiration as bacterial mutants
lacking cytochrome bo oxidase displayed lower extracellular ATP levels. We have also shown that Escherichia coli
(E. coli) and Salmonella actively depleted extracellular ATP and an ATP supplement in culture media enhanced the
stationary survival of E. coli and Salmonella. In addition to E. coli and Salmonella the presence of the extracellular
ATP was observed in a variety of bacterial species that contain human pathogens such as Acinetobacter,
Pseudomonas, Klebsiella and Staphylococcus.
Conclusion: Our results indicate that extracellular ATP is produced by many bacterial species during growth and
extracellular ATP may serve a role in the bacterial physiology.
Keywords: ATP, Secretion, Bacteria, Salmonella, E. coli, Stationary survivalBackground
Adenosine triphosphate (ATP) is one of the most impor-
tant small molecules in the living organisms. It is a
universal energy currency used in many biological pro-
cesses that require energy. Living organisms generate
ATP through respiration and subsequently utilize ATP
to carry out cellular functions that are necessary for
their survival, growth and replication. In addition to its
intracellular roles in storing and supplying energy in
metabolism and enzymatic reactions, ATP also has
signaling functions. ATP has been shown to control the
differentiation of TH17 cells in intestinal lamina propria
[1]. Extracellular ATP has been shown to interact with
P2 receptors to modulate immune response by stimulating
cell migration and cytokine secretion (reviewed in [2,3]).
Recently, ATP was also shown to regulate virulence gene
mgtC in Salmonella [4]. These findings suggest that ATP* Correspondence: sangwei@berkeley.edu
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reproduction in any medium, provided the oris a more versatile molecule than a supplier of energy in
both prokaryotic and eukaryotic organisms.
ATP is present in all living organisms, consistent with
its roles in biological reactions and processes. The in-
tracellular ATP level in Escherichia coli (E. coli) and
Salmonella is reported to be 1–5 mM and changes
according to various environmental and physiological
conditions of bacteria [5-8]. A few reports in recent
years described the detection of the extracellular ATP
from selected bacterial species [9-11]. Iwase et al. re-
ported that ATP was detected at 1–3 μM from the
supernatant of the stationary cultures of Enterococcus
gallinarum isolated from mouse and human feces, but
not from the E. coli and Staphylococcus aureus strains
tested in the same study [10]. In a follow-up study
published recently the same group reported that ATP
release is dependent on glycolysis [11]. An earlier report
by Ivanova et al. showed that bacteria from a variety of
genera including Sulfitobacter, Staleya and Marinobacter
release ATP to concentrations ranging from 0.1 pM to
9.8 pM/colony forming unit (CFU) or 190 μM to
1.9 mM [9]. The purpose and significance of the ATPl Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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extracellular ATP in the intestines was proposed to be
activating a unique subset of lamina propria cells,
CD70highCD11clow cells, which facilitates the differenti-
ation of TH17 cells [1]. Consistent with the hypothesis,
ATP release was detected from commensal bacteria (and
to a lesser extent from Salmonella) cultured in vitro
which may explain the source of the intestinal ATP [1].
In this study, we examined if extracellular ATP is
present in the culture supernatant of Gram-negative
bacteria E. coli and Salmonella and investigated if extra-
cellular ATP has biological functions in bacterial growth
and survival. Here we report that extracellular ATP can
be detected transiently in cultures of Gram-negative bac-
teria E. coli and Salmonella. In addition, we show that
extracellular ATP can also be detected in clinical isolates
of many bacterial species suggesting that ATP release is
not limited to selected bacterial species.
Methods
Bacterial strains, bacterial cultures and reagents
Acinetobacter, Klebsiella and Pseudomonas strains used
in the study are clinical isolates obtained from California
State Department of Health. Staphylococcus strains were
from American Type Culture Collection (Manassas, VA).
Strains of Salmonella enterica Serovar Enteritidis and
Typhimurium were clinical isolates and have been repor-
ted previously [12,13]. The clinical isolates were from
routine surveillance efforts at California State Department
of Health with no patient information and their handling
conforms to the ethical requirements of University of
California and National Institute of Health. E. coli K12
MG1655 was a gift from Dr. Sydney Kustu at the University
of California, Berkeley (Table 1). E. coli mutants and the
parental strain BW25113 were obtained from Coli Genetic
Stock Center, Yale University (New Haven, CT) (Table 2).
Culture media Luria Bertani (LB) broth and M9 min-
imal medium were from BD Diagnostics (Sparks, MD).
All bacteria were cultured in LB broth at 37°C with
shaking at 225 rpm or as indicated. Bacterial culture
density was measured by OD600nm or by plating serially
diluted cultures on LB agar plates and counting colonies
after overnight incubation.
All chemical reagents were from Sigma Aldrich unless
otherwise specified. BacTiter-Glo™ Microbial Cell Viability
Assay Reagent was from Promega (Madison, WI).
Determination of ATP level in bacterial culture
Bacteria were cultured in LB broth at 37°C overnight with
shaking at 225 rpm. Overnight cultures were diluted 1:100
in fresh LB broth and cultured at 37°C with shaking.
Aliquots of cultures were taken after 3, 6, 9, and
24 hours of incubation, and OD600 nm was measured
at each time point. Bacterial cultures were then centrifugedat 16,100 × g for 5 min. Culture supernatant was trans-
ferred to a fresh tube and stored at −80°C until assayed.
ATP level in bacterial supernatant was determined using
BacTiter-Glo™ Microbial Cell Viability Assay Reagent
(Promega, Madison, WI). It is a luciferase – based assay
and the ATP level is determined by measuring lumines-
cence levels and comparing to an ATP standard curve.
One hundred microliters of culture supernatant were
mixed with an equal volume of BacTiter-Glo™ Microbial
Cell Viability Assay Reagent in a 96-well opaque plate and
incubated at room temperature for 5 min. After incuba-
tion, luminescence was read in a SpectraMax M2 plate
reader (Molecular Devices, Sunnyvale, CA). ATP standard
solutions were prepared using adenosine 5-triphosphate
disodium salt hydrate (A2383, Sigma Aldrich, St. Louis,
MO) and a standard curve using 10-fold dilutions of ATP
standard solutions prepared in H2O was included in each
experiment. ATP concentrations in bacterial samples were
determined by comparing to the ATP standard curve for
each assay. LB, H2O or buffer was included in all assays as
the negative controls.
The ATP level in bacterial cells was determined
similarly as described for the culture supernatant. Bac-
teria were cultured in LB broth with shaking at 37°C.
After various culture periods, an aliquot of a culture was
collected for measuring OD600nm and for preparing
bacterial extracts using the perchloric acid extraction
method [14]. Two hundred microliters of bacterial
culture were mixed with 100 μl of ice – cold 1.2 M
perchloric acid and vortexed for 10 seconds. The mix-
ture was incubated on ice for 15 min. and spun down at
16,100 × g for 5 min. at 4°C. Two hundred microliters of
supernatant were transferred to a fresh tube and mixed
with 100 μl of a neutralizing solution containing 0.72 M
KOH and 0.16 M KHCO3. The neutralized extract was
then spun down at 16,100 × g for 5 min. and the
supernatant was transferred to a fresh tube for use for
theATP assay.
ATP depletion Assay
Overnight cultures of bacteria were adjusted to
OD600nm = 3.0 and 1 mL of bacterial culture was
spun down. The culture supernatant was transferred
to a fresh tube and bacterial pellet was resupended
in 1 ml of fresh LB. ATP was added to the culture super-
natant or to the resuspended bacterial cells to 10 μM. All
samples were incubated at 37°C. Aliquots of samples were
collected after various time periods to determine ATP
depletion by culture supernatant or by bacteria cells. ATP
depletion by culture supernatant was determined by
assaying the residual ATP level in the samples. ATP deple-
tion by bacteria cells was determined by first spinning
down bacterial culture to remove bacteria and then deter-
mining the residual ATP level in the culture supernatant.
Table 1 Bacterial strains used
Bacterial strain Characteristics Source or reference
E. coli
MG1655 E. coli K12 derivative Dr. Sydney Kustu, UC Berkeley
BW25113 E. coli K12 derivative Coli Genetic Stock Center, Yale University
KSU-9 Animal isolate of E. coli O157:H7 [12]
KSU-12 Animal isolate of E. coli O157:H7 [12]
Salmonella enterica Serovar Enteritidis
SE2472 Clinical isolate, Phage type 4 [13]
SE6782 Clinical isolate, Phage type 4 [13]
SE8464 Clinical isolate, Phage type 4 [13]
SE8743 Clinical isolate, Phage type 4 [13]
SE10871 Clinical isolate, Phage type 4 [13]
SE4052 Clinical isolate, Phage type 8 [13]
SE4081 Clinical isolate, Phage type 8 [13]
SE4191 Clinical isolate, Phage type 8 [13]
SE4241 Clinical isolate, Phage type 8 [13]
SE4386 Clinical isolate, Phage type 8 [13]
SE2107 Clinical isolate, Phage type unknown [12]
SE2606 Clinical isolate, Phage type 8 [12]
SE0052 Clinical isolate, Phage type 13 [12]
SE0718 Clinical isolate, Phage type 4 [12]
SE0430 Clinical isolate, Phage type 4 [12]
Salmonella enterica Serovar Typhimurium
ST3665 Clinical isolate [12]
ST3744 Clinical isolate [12]
ST3964 Clinical isolate [12]
ST3864 Clinical isolate [12]
ST10428 Clinical isolate [12]
ST2258 Clinical isolate [12]
ST2297 Clinical isolate [12]
ST2298 Clinical isolate [12]
ST2302 Clinical isolate [12]
ST2327 Clinical isolate [12]
Acinetobacter junii
AJ4970 Clinical isolate This study
AJ4978 Clinical isolate This study
Pseudomonas aeruginosa
PA292 Clinical isolate, CDPH* This study
PA4553 Clinical isolate, CDPH* This study
Klebsiella pneumonia
KP2320 Clinical isolate, CDPH* This study
KP7690 Clinical isolate, CDPH* This study
Klebsiella oxytoca
KO76 Clinical isolate, CDPH* This study
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Table 1 Bacterial strains used (Continued)
Staphylococus aureus
SA25923 Clinical isolate ATCC
MRSA43300 Clinical isolate ATCC
* CDPH, California Department of Public Health.
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heating bacterial culture at 65°C for 20 min. before being
used for the ATP depletion assay as described above for
bacteria cells. A sample of LB broth supplemented with
10 μM ATP was included as a control in all assays to
establish the stability of ATP in the LB broth.
ATP depletion of bacteria was also evaluated using
35S – or 32P – labeled ATP. Overnight cultures of
bacteria were spun down and resuspended in equal
volumes of LB supplemented with 10 nM of 35S-α-ATP
or 32P -γ-ATP (1:1,000 dilution) (PerkinElmer, Waltham,
MA). Aliquots of bacterial cultures were collected after
various incubation periods and spun down, and the
culture supernatant was transferred to a fresh tube. The
bacterial pellet was then washed three times with PBS,
resuspended in SOLVABLE aqueous – based solubilizer
(PerkinElmer, Waltham, MA) and lysed at 65 C for
2 hours. Bacterial lysates were centrifuged at 16,100 × g
for 5 min. and the cleared lysate was transferred to a
fresh tube. Radioactivity levels in both culture super-
natant and bacterial lysates were measured on a
DELTA 300 model 6891 liquid scintillation system
(TM Analytic, Inc.). Relative radioactivity in the cul-
ture supernatant and bacterial cells was calculated for
each sample.
Stationary phase survival
Overnight cultures of bacteria were diluted 1:100 in M9
minimal medium and cultured at 37°C with shaking forTable 2 E. coli and Salmonella mutant strains





E. coli (from Coli Genetic Stock center)
Strain/mutant St





ΔcyoD JW7 days. In cultures with ATP supplement, ATP was
added to desired concentration each day from day 2 to
day 6. At day 2 and day 7 of incubation, an aliquot of
bacterial culture was collected and the bacterial concen-
tration (CFU/mL) was determined by plating. The sur-
vival of bacteria was measured by the ratio of bacterial
CFU/mL at day 7 to that at day 2.Mutagenesis of cyo genes
The Δcyo mutants of Salmonella were generated using
the one-step mutagenesis procedure as described previ-
ously [15,16]. Primers used for mutagenesis are listed in
Table 3. Primer pairs cyoA5KO-cyoA3KO, cyoB5KO-
cyoB3KO and cyoC5KO-cyoD3KO were used to amplify
a kanamycin resistance cassette (KanR) from plasmid
pKD4 by PCR and the PCR products were used for
generating the ΔcyoA, ΔcyoB and ΔcyoCD mutants,
respectively [15]. In ΔcyoA and ΔcyoB mutants, the cyoA
or cyoB coding sequence was deleted and replaced with
the KanR. In the ΔcyoCD mutant, both cyoC and cyoD
were deleted and replaced with KanR since the open
reading frames of cyoC and cyoD overlap with each
other. Each mutant was confirmed with flanking primers
(cyoA5 and cyoA3, cyoB5 and cyoB3, or cyoCD5 and
cyoCD3, respectively) and internal primers K1 and K2 in
the KanR cassette (Table 3). Each mutation was trans-
duced into fresh Salmonella by P22 transduction before
being used for further analysis [17].haracteristics Source or reference
2472 ΔcyoA::kan This study
2472 ΔcyoB::kan This study
2472 ΔcyoCD::kan This study







Table 3 Oligo nucleotides used for mutagenesis
Oligonucleotides Used for Sequence
cyoA5KO Mutagenesis of cyoA 5′-ctcaggaaatacaataaaagtttgggatggttgtcattaattgcaggcactgcattactcagtggct
gtaattctgcgctgctggatcccgtgtaggctggagctgcttc-3′
cyoA3KO Mutagenesis of cyoA 5′-caacccttggagttggcggattccgcgtggctcatgtccataccttccattccttcatgcgagctgtgc
tcaccttcaggttgggtcatgcatatgaatatcctccttag-3′
cyoB5KO Mutagenesis of cyoB 5′-ataataagcaatcgttgcctgcgattaccctcgcagctattggggttgtctacggtgatattggt
accagcccgctttatacgcttcgtgaatgtttgtcgtgtaggctggagctgcttc-3′
cyoB3KO Mutagenesis of cyoB 5′-aaattatcactggatgcagtaccgttccatgaacctatcgtcatggtaacgatcgctgcaattatcgtc
gggggactggcgatactggcagtgtaggctggagctgcttc -3′
cyoC5KO Mutagenesis of cyoC/D mutation 5′-tgcattctgttctctattctgtttgctacctatgccgttctggtgaacggcaccgctggcggcccgacaggt
aaggacattttcgaactggtgtaggctggagctgcttc -3′
cyoD3KO Mutagenesis of cyoC/D mutation 5′-tgtagttgaggttccacataatccagatggagcccacaaccaggatggcgatgatcagcacggtaaag
atgaaggccgtcatgttccagcatatgaatatcctccttag -3′
cyoA5 Confirmation of cyoA mutation 5′-atcatgtttacagtaatgta-3′
cyoA3 Confirmation of cyoA mutation 5′-tccgaacatcttatcttcct -3′
cyoB5 Confirmation of cyoB mutation 5′-aggaagataagatgttcgga-3′
cyoB3 Confirmation of cyoB mutation 5′-tcgcgtgcgttaaagtatca -3′
cyoCD5 Confirmation of cyoC/D mutation 5′-tgatactttaacgcacgcga -3′
cyoCD3 Confirmation of cyoC/D mutation 5′-tgcaggtattgcttaaacat-3′
K1 KanR primer for confirmation of mutation 5′-cagtcatagccgaatagcct-3′
K2 KanR primer for confirmation of mutation 5′-cggtgccctgaatgaactgca-3′
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ATP was detected in the culture supernatant of
Gram-negative bacteria Salmonella and E. coli
During a study on the role of bacterial physiological
properties in the Type III secretion of Salmonella, we



















Figure 1 ATP is present in the bacterial culture supernatant
and the extracellular ATP is not due to bacteria contamination.
Overnight culture of Salmonella strain SE2472 was diluted 1:100 in
LB and cultured at 37°C for 3 hours with shaking to reach early log
phase. The overnight (stationary) and 3 hour (early log phase)
cultures were spun down. An aliquot of each culture supernatant
was filtered through a 0.22 μm filter to remove any residual bacteria.
ATP levels in the filtered (hatched bars) or unfiltered culture
supernatant (open bars) were measured. Results are the average of
3 assays and error bars represent standard deviations.bacterial cells and used the culture supernatant as a
negative control. Some culture supernatant samples
unexpectedly displayed readily detectable signals in the
ATP assay. We proceeded to determine if the ATP in
the culture supernatant was due to a bacterial contamin-
ation of the culture supernatant. Salmonella cultures
were grown at 37°C for 3 hours to the early log phase or
overnight to the stationary phase and the cultures were
spun down. The culture supernatant from each sample
was transferred to a fresh tube and an aliquot was
filtered through a 0.22 μm filter. ATP levels were
determined in both filtered and unfiltered supernatant of
the same culture and results were compared. ATP was
detected in the supernatant of both early log and
stationary phase cultures and filtration did not reduce the
ATP levels (Figure 1). The ATP level in the supernatant of
the stationary phase culture was just above the detection
level (at approximately 1 nM), while the ATP level in the
supernatant from the early log phase culture was notice-
ably higher at over 10 nM (Figure 1).
Next we tested if the extracellular ATP is only present
in specific strains of Salmonella such as the clinical
isolate SE2472 we used in the initial analysis. We tested
a collection of clinical strains of Salmonella serovar
Enteritidis (11 isolates) and Typhimurium (17 isolates),
laboratory strains of E. coli K12 MG1655 and BW25113,
and clinical strains of E. coli O157:H7 (2 isolates)
(Table 1). Overnight culture of each bacterial strain was




























Figure 2 ATP is present in the culture media of clinical and
laboratory strains of E. coli and Salmonella during growth.
Overnight culture of each isolate was diluted 1:100 in fresh LB and
cultured at 37°C with shaking. Early log phase bacterial cultures were
harvested at 3 hours of incubation and ATP assays were carried out
with culture supernatant. The ATP concentration was plotted for
each bacterial isolate of E. coli, Salmonella enterica Serovar Enteritidis
(SE) or Salmonella enterica Serovar Typhimurium (ST). The experiment










































Figure 3 Extracellular ATP level changes during bacteria growth. Ove
or BW25113 (D), were diluted 1:100 in LB broth and cultured at 37°C with
OD600nm and culture supernatant was harvested for ATP assays. The ATP le
plotted against incubation period. Results are the average from 3 to 8 expe
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supernatant was determined (Figure 2). The results
showed that various bacterial strains displayed different
levels of ATP in the culture supernatant; nevertheless
extracellular ATP was detected in all isolates (Figure 2).
These results raised a possibility that extracellular ATP
is indeed present in the culture supernatant during
growth.
ATP level in the culture supernatant is regulated by
growth phase
Since we detected a higher ATP level in the culture
supernatant of the log phase cultures than that of the
stationary phase cultures (Figure 1), we next investigated
systematically if the ATP level in the culture supernatant
changes during bacterial growth. Four bacterial strains
were used for the analysis: E. coli K12 MG1655, E. coli
K12 BW25113, Salmonella enterica Serovar Enteritidis
SE2472 and Salmonella enterica Serovar Typhimurium
ST14028s (Table 1). For each strain, an overnight culture
of bacteria was diluted 1:100 in fresh LB broth and
cultured at 37°C with shaking. Aliquots were taken at
various time points to measure the bacterial density at
OD600nm and to determine the ATP level in the culture
supernatant. The ATP level in the culture supernatant










































rnight cultures of Salmonella SE2472 (A) or ST14028s (B), E. coli K12 (C)
shaking. Aliquots were collected at various time points for measuring
vels in the culture supernatant were normalized against OD600nm and
riments and error bars represent standard deviations.
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displayed a bell – shaped curve indicating that the ATP
level in the culture supernatant changes according to the
growth phase. The extracellular ATP levels peaked at 12
to 30 nM/OD600nm at 6 hours of growth that corre-
sponds to the transition from the log phase to the
stationary phase. The extracellular ATP levels then
decreased as the bacterial cultures entered the stationary
phase and all strains tested displayed very low extra-
cellular ATP levels compared to those in the log phase
cultures (Figure 3).
Cytochrome bo oxidase contributes to ATP in culture
supernatant
We have shown above that extracellular ATP can be
detected in the culture supernatant during bacterial
growth and its level peaked at the end of the log phase of
growth. Next we determined if extracellular ATP is associ-
ated with cell respiration. ATP in bacteria is produced by
ATP synthase powered by the proton gradient generated
by the terminal oxidases [18]. E. coli and Salmonella have
a variety of terminal oxidases that are active under differ-
ent growth conditions. The main oxidases for the culture
conditions we used (LB broth, 37°C, aerobic growth)
include cytochrome bo oxidase, cytochrome bd I and II
oxidases [18]. To determine if and which oxidase or
oxidases contribute to the ATP detected in the culture
supernatant, we obtained a panel of mutants that each
contained a deletion mutation in one of the subunits
encoding the terminal oxidases [19] [Coli Genetic Stock
Center, Yale University]. The growth properties and ATP
levels in the culture supernatant from each mutant were
determined (Table 3).
All strains of terminal oxidase mutants grew normally
under the assay condition, and the only exception was
the cytochrome bd-I oxidase mutant ΔcydB that
displayed a growth delay in the log phase (Table 4 and
data not shown). The peak extracellular ATP level of the
ΔcydB mutant at 6 hours of incubation was very low at
1.3 ± 2.2% of that of the parental strain. However;
because of the growth defect of the ΔcydB mutant it was
not possible to distinguish if the decreased ATP level
was caused directly by the lack of the cytochrome bd I
oxidase activity or indirectly by the slow growth of theTable 4 Peak ATP levels in culture supernatant of terminal ox
Enzyme Mutant Growth prop
Cytochrome bd-I oxidase ΔcydB Defective
Cytochrome bd-II oxidase ΔappC Normal
Cytochrome bo oxidase ΔcyoA Normal
ΔcyoC Normal
ΔcyoD Normal
Results are the average of three assays with standard deviations.ΔcydB mutant. Therefore the ΔcydB mutant was not
analyzed further. In contrast to the cytochrome bd-I
oxidase mutant ΔcydB, all mutants of the cytochrome
bo oxidase and the cytochrome bd II oxidase grew
normally (data not shown). The peak extracellular ATP
levels in mutants lacking one of the subunits of cyto-
chrome bo oxidase (ΔcyoA, ΔcyoC and ΔcyoD mutants)
ranged from 26.1% to 36.6% of that of the wild type level
(p < 0.05, Student’s t-test). The peak ATP level from the
mutant lacking cytochrome bd II oxidase (ΔappC) was
94.8 ± 2.5% of that of the parental strain; the difference
is small but is statistically significant (p < 0.05, Student’s
t-test) (Table 4).
The cytochrome bo oxidase mutants of E. coli were
analyzed further to characterize the extracellular ATP
levels during growth. While the extracellular ATP levels
in the Δcyo mutants displayed time courses similar to
that of the parental strain, the peak levels were signifi-
cantly lower than that observed in the parental strain
(Figure 4A). These results suggest that cytochrome bo
oxidase contributes to the extracellular ATP even
though it had no significant influence on the growth of
E. coli under the conditions used for the assay (LB broth,
37°C, with shaking). The cytochrome bo oxidase was then
mutated in Salmonella to determine if the oxidase
contributes to the extracellular ATP in Salmonella as
observed in E. coli. Deletion mutations were generated for
cyoA, cyoB and cyoC/D [15,16] and the mutants were
assayed for their extracellular ATP levels during growth.
Similar to what was observed in E. coli, the Δcyo deletion
mutants produced less extracellular ATP compared to the
wild type parental strain (Figure 4C).
The decreased levels of the extracellular ATP of the
Δcyo mutants could be due to an overall ATP produc-
tion defect in the mutants or due to a decreased release
of ATP. To determine which the case is for the Δcyo
mutants, the ATP levels were determined in the bacterial
whole culture and plotted for each mutant. As shown in
Figure 4B and D, the Δcyo mutants of both E. coli and
Salmonella contained comparable quantities of ATP in
the bacterial whole cultures. Therefore, the decreased
levels of extracellular ATP from the cytochrome bo
oxidase mutants of E. coli and Salmonella were not due
to any obvious ATP synthesis deficiency.idase mutants of E. coli
erty % of the WT level p, student’s t-test
1.3 ± 2.2 < 0.05
95.0 ± 2.5 < 0.05
25.0 ± 3.7 < 0.05
36.6 ± 1.5 < 0.05
26.1 ± 5.4 < 0.05
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Figure 4 The Δcyo mutants of E. coli BW25113 and Salmonella SE2472 have lower extracellular ATP levels during growth. Overnight
cultures of wild type (WT) or Δcyo mutants of E. coli (A and B) or Salmonella (C and D) were diluted 1:100 in fresh LB broth and cultured at 37°C
with shaking. Aliquots were collected at various time points and ATP assays were carried out with culture supernatant or whole culture. The ATP
levels in the culture supernatant (A and C) or whole culture (B and D) were normalized using OD600nm and plotted against the incubation
period. Results are the average of 3 experiments and error bars represent standard deviations.
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As shown in Figures 3 and 4 the presence of extra-
cellular ATP in the culture supernatant of E. coli and
Salmonella peaked at the late log phase. To investigate
why the extracellular ATP level decreases as bacteria
enter into stationary phase of growth, we measured if
Salmonella and E. coli cultures deplete ATP in the
culture medium. Overnight cultures were spun down
and the culture supernatant was removed. Bacteria were
then resuspended in fresh LB supplemented with 10 μM
ATP and the ATP level in the culture medium was
measured at various time points of incubation. The ATP
level decreased rapidly in culture medium incubated
with either E. coli or Salmonella (Figure 5A and B). The
ATP depletion requires live bacteria as heat-killed
bacteria, culture supernatant or LB broth depleted little
of supplemented ATP (Figure 5A and B). Over 2 h of in-
cubation live bacteria depleted approximately 10 μM
ATP, which was several magnitudes higher than the
usual 20–100 nM of extracellular ATP detected in E. coli
or Salmonella cultures (Figures 2, 3 and 4). These resultssuggest that the capacity of ATP depletion by E. coli and
Salmonella far exceeds the peak level of the extracellular
ATP detected in bacterial culture supernatant.
Since bacterial cells instead of culture supernatant
deplete ATP (Figure 5A and B), we reasoned that the
reduction of ATP level in the culture supernatant could
be due to hydrolysis or degradation of ATP at the bac-
terial cell surface. Alternatively, ATP level can become
lower due to an uptake by bacteria although no ATP
transporter or uptake system has been reported in
bacteria. To explore the fate of the extracellular ATP, we
incubated bacteria with 35S -α-ATP and quantified the
radioactivity in the culture supernatant and bacterial
pellet. ATP transported back into bacteria should be
detected by cell-associated radioactivity whether it
remains as ATP or is hydrolyzed subsequently into ADP
or AMP. Stationary phase cultures of Salmonella and
E. coli were spun down and resuspended in fresh LB
broth supplemented with 32S-α-ATP. After various
periods of incubation, bacteria were spun down,
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Figure 5 Live bacteria deplete ATP in the culture medium. (A) and (B) Live or heat – killed E. coli K12 (A) or Salmonella SE2472 (B) were
spun down and incubated at 37°C in fresh LB supplemented with 10 μM ATP. Culture supernatant from live bacteria was supplemented with ATP
to 10 μM. ATP depletion by bacteria cells or culture supernatant was measured by the residual ATP level in culture medium after various culture
periods of incubation at 37°C. The residual ATP levels were plotted against the incubation period. (C) and (D) Free and cell-associated ATP in
E. coli (C) or Salmonella (D) culture incubated with S35-α-ATP or P32-γ-ATP. The relative levels of radioactivity in culture supernatant and bacterial
cells were determined and plotted against the incubation period. Each experiment was performed three times and results are from a
representative experiment.
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radioactivity remained in the culture supernatant and very
little radioactivity was detected in bacterial cell pellet of
Salmonella or E. coli (Figure 5C and D).
We next tested if the extracellular ATP was used in
kinase reactions to phosphorylate proteins and other cell
surface components. ATP depletion assay was carried
out using 32P -γ-ATP as described above for 32S-α-ATP.
Quantitation of radioactivity in the culture supernatant
and bacterial pellet showed that radioactivity was
present almost exclusively in the culture supernatant
(Figure 5C and D). This suggests that ATP was most
likely hydrolyzed or degraded by bacteria on their
surface and was not transported into bacteria or used
for phosphorylating bacterial components.
Extracellular ATP enhanced stationary survival of E. coli
and Salmonella
The presence of the extracellular ATP in bacterial
cultures was unexpected since it likely represents a loss
of the valuable small molecule to bacteria. The extra-
cellular ATP could be an unavoidable cost to bacterial
respiration or could be beneficial to bacteria in someaspects. We next determined if the extracellular ATP has
any impact on the growth and survival characteristics of
bacteria. Since extracellular ATP level was found to de-
crease during the stationary phase of growth (Figure 3),
we determined if the extracellular ATP is beneficial to
bacteria at stationary phase and if ATP supplement could
enhance the bacterial survival. Salmonella and E. coli were
cultured for 7 days and exogenous ATP was added to the
cultures. We chose to use 10 μM or 100 μM to supple-
ment bacterial culture since the ATP depletion assays
showed that Salmonella and E. coli depletes ATP at
approximately 5 μM/hr (Figure 5A and B) and high con-
centrations of ATP would allow ATP level in the bacterial
cultures to stay elevated for an extended period of time.
Survival of bacteria was determined by the ratio of bacter-
ial CFU/mL after 7 days of incubation to that after 1 day
of incubation (Figure 6). Our results showed that an ATP
supplement increased the survival of the bacterial strains
tested. The dosage response varied in different strains.
Salmonella responded best to 10 μM ATP, while E. coli
responded equally well to 10 μM and 100 μM ATP. The






















Figure 6 ATP supplementation increases the stationary survival
of bacteria. E. coli K12, Salmonella enterica Serovar Enteritidis (SE) or
Salmonella enterica Serovar Typhimurium (ST) was cultured in M9
minimal medium or M9 minimal medium supplemented with 10 μM
or 100 μM of ATP. The rate of survival was determined by
comparing bacterial CFU/mL after 7 days of incubation to that after
1 day of incubation. The experiment was performed three times and
results are from a representative experiment performed in triplicate.
Error bars represent standard deviation. * p < 0.05, Student’s t-test.
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http://www.biomedcentral.com/1471-2180/13/301Extracellular ATP was detected in several Gram-negative
and Gram-positive bacterial species
In addition to Gram-negative bacterial species E. coli
and Salmonella, other bacterial species were tested for
the presence of ATP in the culture medium to determine
if the phenomenon is limited to Enterobacteriaceae or is
present in more bacterial families such as Acinetobacter,
Klebsiella, Pseudomonas and Staphylococcus. Clinical
isolates of various human pathogenic bacterial species
were tested for the presence of ATP in culture medium
during their growth in vitro and the ATP levels in the
culture supernatant were determined. The peak values of
the ATP concentration in the culture medium and the
incubation time when the ATP levels peaked are listed in
Table 5. ATP was detected in the culture supernatant of











Results are the average of three assays with standard deviations.time points varied from strain to strain, all bacterial strains
displayed the presence of growth phase dependent ATP in
the culture supernatant (Table 5). This result suggests that
the presence of extracellular ATP is not restricted to
Enterobacteriaceae and instead can be detected in many
bacterial families. For most bacterial strains the ATP levels
detected were comparable to those observed in Salmon-
ella and E. coli which peaked around 10 – 30 nM/
OD600nm (Figures 3 and 4). Some bacterial strains,
however, displayed much higher or lower ATP levels. For
example, a clinical isolate of Acinetobacter junii (AJ4970)
had a peak extracellular ATP level of > 250 nM/OD600nm,
several fold higher than the peak concentrations observed
in most bacterial strains (Table 5). In contrast a clinical iso-
late of Klebsiella pneumoniae had a low peak ATP level of
approximately 1 nM/OD600nm (Table 5). The extracellular
ATP did not appear to display a species – specific pattern
and strains from the same bacterial species could have very
different peak ATP levels (e.g. AJ4970 at 255.2 ± 56.8 nM/
OD600nm vs. AJ4978 at 17.0 ± 1.1 nM/OD600nm), suggesting
that extracellular ATP is a common phenomenon to many
bacterial species while the dynamics of ATP release is
different in each bacterial strain.
The ATP levels of two isolates of Acinetobacter junii
AJ4970 and AJ4978 were analyzed in more details to
compare the quantity of ATP in the culture supernatant
to that in bacterial cells. Overnight culture of AJ4970 or
AJ4978 was diluted 1:100 in fresh LB broth and cultured
at 37°C with shaking. Aliquots were collected at various
time points and the ATP levels in the culture supernatant
and bacterial pellet were determined (Figure 7A and B).
The ratio of total ATP in the supernatant to that in the
bacterial pellet from the same volume of bacterial culture
was also determined (Figure 7C). The ATP level in the
culture supernatant of AJ4970 reached a peak level of over
300 nM at 6 hours of incubation (Figure 7A) and the ratio
of ATP in the culture supernatant to that in the pellet
(total ATP in supernatant/total ATP in the pellet) peaked
at 0.58 at 9 hours of incubation (Figure 7C). ByPeak hour Peak level (nM/OD)
6 255.2 ± 56.8
6 17.0 ± 1.1
6 25.5 ± 1.1
3 20.5 ± 0.6
9 9.3 ± 0.5
9 1.0 ± 0.0
3 31.1 ± 4.0
6 21.4 ± 3.5


















































































Figure 7 ATP levels in the cultures of Acinetobacter junii. Overnight cultures of two clinical isolates of Acinetobacter junii AJ4970 and AJ4978
were diluted 1:100 in fresh LB broth and cultured at 37°C with shaking. Aliquots were collected at various time points and ATP levels in the
culture supernatant and the bacterial pellet were determined. (A) ATP levels in the culture supernatant. ATP concentrations were determined and
plotted against the incubation period. (B) ATP levels in the bacterial pellet. Total ATP levels in the bacterial pellet were normalized against
OD600nm of each culture and plotted against the incubation time period. (C) Ratio of quantity of ATP in the culture supernatant to that of the
bacterial cells. Acinetobacter junii cultures were spun down and separated into culture supernatant and cell pellet. ATP levels in each fraction were
determined. The ratio of ATP from supernatant to that of bacterial cells from the same volumes of cultures was plotted against the incubation
period. Results are the average of 4 experiments and error bars represent standard deviations.
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http://www.biomedcentral.com/1471-2180/13/301comparison AJ4978 displayed much lower ATP levels in
the culture supernatant as well as lower supernatant/pellet
ratios of ATP (Figure 7A and C). The ATP levels in the
bacterial cells were comparable in AJ4970 and AJ4978,
except that AJ4978 had a higher intracellular ATP level at
3 hours of incubation (Figure 7B).
Discussion
We report here that ATP can be detected in the culture
supernatant of a wide variety of bacterial species includ-
ing both Gram-positive and Gram-negative bacteria of
laboratory and clinical strains (Figure 2 and Table 5).
The concentrations of extracellular ATP (from several
nanomolar to several hundred nanomolar) were much
lower than the 1–5 mM reported for intracellular ATP
[6-9], and total extracellular ATP represents up to 3 to
5% of that in bacterial culture (Figure 4). One noticeable
exception is Acinetobacter junii AJ4970 that had ratios
of extracellular to intracellular ATP > 0.5 (Figure 7C),
suggesting that a significant portion of total ATP was
present in the culture supernatant of this bacterial
strain.The extracellular ATP is unlikely an artifact due to any
contamination of culture supernatant by bacterial cells
since filtration did not reduce the ATP level (Figure 1).
However, we have yet to establish the mechanism of
how ATP was released into the culture medium. The
simplest explanation is that ATP was released from dead
and lysed bacteria. This explanation is plausible for low
extracellular ATP levels when total extracellular ATP is
less than 5% of the intracellular ATP levels; however, it
cannot explain the high extracellular ATP levels ob-
served with AJ4970 which has comparable quantities of
extracellular ATP compared to the intracellular ATP
(Figure 7C). In addition we have shown that live bacteria
of both E. coli and Salmonella (but not dead bacteria
or culture supernatant) are able to actively deplete
ATP at approximately 5 μM/hr or 83 nM/min (Figure 5A
and B) – a very high rate compared to the peak extracellular
ATP concentration of 15 nM to 35 nM/OD600nm in
E. coli and Salmonella cultures (Figure 4). Thus the
quantity of ATP released into culture supernatant is
likely to be much higher than that detected in the
supernatant. Genetic analysis showed that ATP release
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against the bacterial cell death and lysis as the sole
source of the extracellular ATP (Figure 4).
We show here that the extracellular ATP levels are
regulated by growth phase in all bacterial species tested
(Figure 3 and Table 5). They peaked at the late log to
early stationary phase of growth for most strains and de-
creased to much lower or undetectable levels by 24 hours
of growth. The growth phase – dependent presence of
extracellular ATP suggests a dynamic process of ATP
release and depletion, and the observed level of ATP in
the culture supernatant is most likely the combined
effect of the two processes. Live E. coli and Salmonella
(but not dead bacteria or culture supernatant) appear to
actively deplete extracellular ATP and the depletion
was not due to uptake (Figure 5). Either α-labeled or
γ-labeled phosphate on supplemental ATP remained
in the culture medium, suggesting that the extracellu-
lar ATP was hydrolysed or degraded at the bacterial
surface (Figure 5).
There have been a few reports on the extracellular ATP
from bacteria [1,9,10]. Iwase et al. reported the detection
of ATP in the culture supernatant of Enterococcus species,
but not strains of E. coli or Staphylococcus aureus (Iwase,
2010 #195). A possible reason for the discrepancy between
their results and ours is that they used overnight cultures
which had very low ATP levels in our study as well, while
cultures at late log and early stationary phases had much
higher extracellular ATP levels (Figures 3 and 4). Another
report by Ivanova et. al reported the presence of extra-
cellular ATP from cultures of Sulfitobacter, Staleya
and Marinobacter at 190 μM to 1.9 mM. These levels
approach those reported for intracellular ATP of 1 – 3 mM
and are much higher than we observed. If those levels are
accurate it would suggest that the total quantity of extra-
cellular ATP far exceeds that of intracellular ATP since
the volume of cell culture medium is at least several
hundred times higher than that of bacterial cells. We do
not know if the differences between results by Ivanova
et al. and our results were due to the different bacterial
species used or to technical reasons. After we finished the
experiments reported here and were preparing this manu-
script, Hironaka et al. reported a follow-up study to their
previous report that ATP is secreted by gut commensal
bacteria [11]. In the new report, they demonstrated that
ATP can be detected in the culture supernatant of log
phase cultures of E. coli, Pseudomonas aeruginosa and
Staphylococcus aureus but not the stationary cultures, in
agreement with our observations reported here [11]. They
also reported that glycolysis is essential for ATP secretion
which supports our notion that cytochrome bo oxidase
and respiration are important for ATP release (Figure 4).
Reports in recent years have shown that eukaryotic
cells can release ATP without lysis through exocytosis ofATP-containing granules, plasma membrane carriers or
large conductance channels [2,3,20,21]. Cells of innate
immunity such as dendritic cells and macrophages sense
ATP as a danger signal through purinergic receptors of
P1 and P2 family and initiate a pro-inflammatory
response [2,3,20]. It is possible that ATP serves as a
signaling molecule to regulate both eukaryotic cells and
bacteria in the bacteria – host interaction. Atarashi et al.
reported that TH17 T-helper cells in the intestinal lamina
propria are induced by intestinal ATP [1]. Germ – free
mice were shown to have lower luminal concentration of
ATP and fewer numbers of TH17 cells, and the number of
TH17 cells increased by systemic or rectal administration
of ATP [1]. The source of intestinal ATP was not
identified but was presumably commensal bacteria,
which is supported by our findings that many bac-
terial species release ATP. A recent report by Lee and
Groisman demonstrated that ATP regulates Salmon-
ella virulence gene mtgC [4]. We have shown that
ATP supplement of 10 μM or 100 μM increased the
survival of Salmonella at the stationary phase (Figure 6).
The ATP supplement of 10 μM or 100 μM was much
higher than the observed extracellular ATP concentrations
in bacterial cultures (~ 30 to 50 nM), but the concentra-
tion of the ATP supplement was still much lower than the
intracellular ATP concentrations of 1 mM – 10 mM
reported for eukaryotic cells [22-24]. An intracellular
pathogen such as Salmonella is likely to be exposed
to ATP inside host cells and our results suggest that
Salmonella is capable of utilizing ATP to increase its
survival, possibly by using extracellular ATP as a
nutrient and/or a signaling molecule. Regardless of
the exact role of extracellular ATP, intracellular path-
ogens such as Salmonella would have access to host
ATP inside host cells and the ability to use extra-
cellular ATP should be beneficial to the intracellular
pathogens.
We have detected extracellular ATP from a variety of
bacterial species, suggesting that extracellular ATP is not
limited to any particular bacterial species. The biological
purpose of ATP release is yet to be determined. Since
bacteria likely exist as communities in their natural state,
a possible role for the extracellular ATP is to function as
a nutrient or a signaling molecule in the bacterial
communities. It can be a signal in quorum sensing as
it changes with bacterial density (Figures 3 and 7).
Though less likely, ATP release could be an altruistic
action of individual bacterium that facilitates the for-
mation and survival of bacterial communities. Indeed
our results show that exogenous ATP increased the
stationary survival of E. coli and Salmonella (Figure 6).
It is possible that ATP released from some members
of the bacterial communities may supply energy to
other members and hence help the communities
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http://www.biomedcentral.com/1471-2180/13/301thrive. The role of extracellular ATP and the mecha-
nisms of ATP release need further characterization;
nevertheless the current study indicates that ATP is
present extracellularly and may have additional func-
tions in bacterial physiology in addition to its role as
an energy supplier.
Conclusions
We have detected extracellular ATP in the culture
supernatant of several Gram – positive and Gram –
negative bacterial species. The extracellular ATP level in
all bacterial strains tested was growth-phase dependent
with the highest level at the late log phase of growth.
The presence of extracellular ATP and the dynamic
changes in its level suggest that ATP may have import-
ant functions extracellularly in addition to its long-
established roles intracellularly.
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